Fig. 10: Nanoparticle treatment reshapes immune microenvironment and potentiates the therapeutic effects of radiotherapy in PVPF8 murine gliomas. | Nature Communications

Fig. 10: Nanoparticle treatment reshapes immune microenvironment and potentiates the therapeutic effects of radiotherapy in PVPF8 murine gliomas.

From: STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Fig. 10: Nanoparticle treatment reshapes immune microenvironment and potentiates the therapeutic effects of radiotherapy in PVPF8 murine gliomas.The alternative text for this image may have been generated using AI.

C57 mice received intracranial implantation of 7.5×104 PVPF8 cells, radiotherapy (RT, 3 Gy×3) and two administrations of saline or P-LNP/diABZI (2.5 mg/kg diABZI) through intravenous injections. a Histology of the brains was evaluated by H&E staining. Scale bar, 2.5 mm; inset scale bar, 500 μm. b Freshly dissected brains were analyzed by flow cytometry for immune composition, TAMC, and CD8+ T cell phenotypes. n = 5 mice. Statistics were determined by two-sided Student’s t-test; data are presented as mean + /- SEM. Representative dot plots of flow cytometric analysis are provided in Supplementary Fig. 20. c Survival curves of the PVPF8 tumor-bearing mice received RT (3 Gy×3) and two administrations of saline or P-LNP/diABZI (2.5 mg/kg diABZI) through intravenous injections. n = 9 mice. Statistics were determined by Log-rank method. Source data are provided as a Source Data file.

Back to article page